about
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...
Read More
3.43
-0.07
(-2.00%)
922.4K
XNAS Volume
XNAS 22 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
X4 Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..